G17V (p.Gly17Val) variant of AMH (Anti-Muellerian hormone)
G17V (p.Gly17Val) in AMH (Anti-Muellerian hormone) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes population frequency data, published literature, and structural context.
G17V (p.Gly17Val) variant details
- p.Gly17Val
- gnomAD 19-2249382-G-T
- Missense
- Variant Prioritization Score for Impact Estimate 0.435
- REVEL 0.45
- CADD 23.40
- PolyPhen-2 0.95
- SIFT 0.00
- Population evidence available
- Structural context available
- Literature evidence available